ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

Vitamin B-12 Deficiency and Pseudo Thrombotic Microangiopathy: A Case Series

C. Jones1, R. Kumar2

1University of Louisville School of Medicine Internal Medicine Residency Program, Louisville, United States, 2University of Louisville Division of Medical Oncology and Hematology; Brown Cancer Center, Louisville, United States

Abstract Number: PB0877

Meeting: ISTH 2021 Congress

Theme: Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies » Non HUS/TTP Microangiopathies

Background: Vitamin B12 (cobalamin) deficiency, defined as a serum cobalamin level < 200 pg/mL, is a common problem. Most clinicians are aware that cobalamin deficiency causes megaloblastic anemia, hypersegmented neutrophils, and subacute combined degeneration of the dorsal spinal column. However, many general clinicians are unaware that cobalamin deficiency can cause pseudo-thrombotic microangiopathy (TMA). Psuedo-TMA presents similarly to the life-threatening condition thrombotic thrombocytopenic purpura (TTP), with laboratory evidence of hemolytic anemia. However, it is distinguished from TTP by very high levels of lactate dehydrogenase (LDH) and reticulocytopenia. Due to the extraordinarily high mortality rate of untreated TTP and its overlap in presentation with pseudo-TMA, pseudo-TMA is often treated with plasmapheresis, when simple vitamin replacement is what’s needed.

Aims: We present 3 cases of pseudo-TMA secondary to cobalamin deficiency. Our case series is important because although this pathology is known, it is not widely taught in basic medical education, leading to incorrect treatment with expensive and risky plasmapheresis.  

Methods:

Case 1 Case 2 Case 3
90 year old female with fatigue, weakness, anorexia, and lethargy. Found to have pernicious anemia with an intrinsic factor 100 times the upper limit of normal. Treated with 5 days of IM cyanocobalamin 1000 mcg, followed by daily sublingual tablets for life.

***[It is important to note that ALL 3 cases had complete resolution of symptoms, with near normal labs on 3 month follow up after vitamin B12 replacement.]

32 year old male with shortness of breath for two weeks. TTP incorrectly diagnosed, so he had urgent plasmapheresis. He developed hives from the procedure, and it was stopped. Found to have severe B12 deficiency, and received 4 days of IM cyanocobalamin 1000 mcg, followed by daily sublingual tablets for life. A 35 year old male with a history of alcohol abuse had fatigue, fevers, chills, and diarrhea. He had resolution of his GI symptoms, but persistent fatigue so he sought medical attention. Found to have severe macrocytic anemia and markedly elevated anti-parietal and anti-intrinsic antibodies. He received 5 days of IM cyanocobalamin 1000 mcg, followed by monthly injections.

Results:

PERTINENT LABS Case 1 Presentation Case 1 Discharge Case 2 Presentation Case 2 Discharge

Case 3 Presentation

Case 3 Discharge

Hemglobin (g/dL) 3.6 9.5 5.7 8.4 6.4 8.3
Platelets (10×3/mm3) 50 104 82 76 187 114
MCV (HI) 104.9 91.9 108.8 100.2 125.7 108.6
LDH (units/L) 2,032 596 3,352 711 5,622 3,163
Haptoglobin (mg/dL) <15 27 < 15 44 < 15 < 15
Reticulocyte Index (RI) 0.48 2.0 1.0 1.04 0.59 3.4
ADAMTS 13 > 50% N/A 77.1% N/A 73% N/A
Cobalamin (pg/mL) < 50 > 1,500 < 50 2,079 < 50 1,918
Peripheral Smear Anisocytosis, poikilocytes, 1+ schisto-cytes, polychromasia, slight burr cells, hypersegmented neutrophils, rouleaux, slight basophilic stripling No schistocytes 1+ schistocytes, 3+ anisocytosis, 1+ macrocytes, tear drop cells, occasional ovalocytes, and hypochromia No schistocytes 4-5 schistocytes per HPF, anisocytosis, elliptocytosis, macrocytosis, thrombocytopenia, hypersegmented neutrophils, no inclusion bodies noted 1+ schistocytes, polychromasia, anisocytosis, poikilocytes, 1+ macrocytes, and occasional burr cells, teardrop cells, and ovalocytes.  

Conclusions: All three cases had the following similarities: schistocytes, undetectable haptoglobin, thrombocytopenia, normal renal function, significantly high levels of LDH (>2000 IU/L), and recitulocytopenia, with a low reticulocyte index (RI <2). These findings highlight how difficult it can be to distinguish TTP from psudeo-TMA, but also feature differences. The high LDH and low RI can be explained from a hypo-proliferative bone marrow response from insufficient cobalamin levels. None of the patients had a low ADAMTS13 level, nearly excluding TTP since ADAMTS13 activity less than 10% is a relatively specific finding in TTP. The risk of an adverse event in plasmapheresis is nearly 30%, and the cost exceeds $100,000 in the setting of TTP. This unnecessary risk and enormous financial burden can be eliminated if replacement of cobalamin is given in a timely manner. Our hope is that this case series prevents erroneous treatment in the future.  

To cite this abstract in AMA style:

Jones C, Kumar R. Vitamin B-12 Deficiency and Pseudo Thrombotic Microangiopathy: A Case Series [abstract]. Res Pract Thromb Haemost. 2021; 5 (Suppl 2). https://abstracts.isth.org/abstract/vitamin-b-12-deficiency-and-pseudo-thrombotic-microangiopathy-a-case-series/. Accessed June 25, 2022.

« Back to ISTH 2021 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/vitamin-b-12-deficiency-and-pseudo-thrombotic-microangiopathy-a-case-series/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley